Agape ATP Corporation (ATPC)
- Previous Close
2.4200 - Open
2.3500 - Bid 1.6800 x 200
- Ask 2.8800 x 200
- Day's Range
2.2500 - 2.3600 - 52 Week Range
0.9000 - 8.0000 - Volume
21,549 - Avg. Volume
2,108,237 - Market Cap (intraday)
112.512M - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6300 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. The company operates through Skin care, health and wellness; and Green energy segments. It offers two series of programs that consist of various services and products under the ATP Zeta Health Program and E.A.T.S. names. The company also provides ionized and high bioavailability nutrients to enhance absorption at the cellular level, energized mineral concentrate, soy protein isolate powder, LIVO5, and solutions for sustainability and energy savings; and promotes environmental stewardship. In addition, it promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. Agape ATP Corporation was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.
www.agapeatpgroup.com16
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ATPC
View More
Performance Overview: ATPC
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATPC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATPC
View MoreValuation Measures
Market Cap
121.01M
Enterprise Value
119.34M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.12
Price/Book (mrq)
62.61
Enterprise Value/Revenue
90.22
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-186.77%
Return on Assets (ttm)
-35.80%
Return on Equity (ttm)
-78.80%
Revenue (ttm)
1.32M
Net Income Avi to Common (ttm)
-2.47M
Diluted EPS (ttm)
-0.6300
Balance Sheet and Cash Flow
Total Cash (mrq)
2.04M
Total Debt/Equity (mrq)
18.81%
Levered Free Cash Flow (ttm)
-1.79M